Refine
Has Fulltext
- yes (6)
Is part of the Bibliography
- yes (6)
Document Type
- Journal article (6)
Language
- English (6)
Keywords
- thymus (2)
- ALK-1 (1)
- B-cells (1)
- CD30 (1)
- CD8(+) (1)
- LESA (1)
- MTCH2 (1)
- Merkel cell carcinoma (1)
- PD-L1 (1)
- Stevens-Johnson syndrome (1)
- T-antigens (1)
- activation (1)
- adults (1)
- albumins (1)
- anaplastic large cell lymphoma (1)
- antitumor immunity (1)
- apoptosis (1)
- autoimmune disease (1)
- breast cancer (1)
- c-flip (1)
- cell-death (1)
- classification (1)
- drug metabolism (1)
- eczematous dermatitis (1)
- enzyme metabolism (1)
- expression (1)
- features (1)
- gene (1)
- gene expression (1)
- gene induction (1)
- heptaocytes (1)
- human heptocytes (1)
- imaging (1)
- immune cell infiltration (1)
- in-vivo (1)
- induction (1)
- lung cancer (1)
- lymphocytes (1)
- lymphoma (1)
- mediated apoptosis (1)
- mesenchymal stem cells (1)
- myasthenia (1)
- myasthenia gravis (1)
- oragnoids (1)
- pathology (1)
- pediatric lymphoma (1)
- polymavirus (1)
- primary cells (1)
- programmed necrosis (1)
- psoas muscle (1)
- responses (1)
- surgery (1)
- survival (1)
- targeted (1)
- tertiary lymphoid structures (1)
- thymic carcinoma (1)
- thymic epithelial tumor (1)
- thymitis (1)
- thymoma (1)
- toxic epidermal necrolysis (1)
- translocation (1)
Institute
The molecular pathogenesis of thymomas and thymic arcinomas (TCs) is poorly understood and results of adjuvant therapy are unsatisfactory in case of metastatic disease and tumor recurrence. For these clinical settings, novel therapeutic strategies are urgently needed. Recently, limited sequencing efforts revealed that a broad spectrum of genes that play key roles in various common cancers are rarely affected in thymomas and TCs, suggesting that other oncogenic principles might be important.This made us re-analyze historic expression data obtained in a spectrumof thymomas and thymic squamous cell carcinomas (TSCCs) with a custom-made cDNA microarray. By cluster analysis, different anti-apoptotic signatures were detected in type B3 thymoma and TSCC, including overexpression of BIRC3 in TSCCs. This was confirmed by qRT-PCR in the original and an independent validation set of tumors. In contrast to several other cancer cell lines, the BIRC3-positive TSCC cell line, 1889c showed spontaneous apoptosis after BIRC3 knock-down. Targeting apoptosis genes is worth testing as therapeutic principle in TSCC.